Ben’s Friends, Antidote Technologies, and MyRareData Collaborate to Offer Virtual Rare Disease Clinical Trial Recruitment

Partnership will provide 75,000+ patients across more than 40 rare conditions with access to critical clinical trial information online

New York, NY (June 1st, 2020) — Ben’s Friends, Antidote Technologies, and MyRareData today announced a collaboration to bring information about clinical trials, including virtual pre-screening, to the rare disease community. With an approved treatment available for just five percent of all rare diseases, advancing medical research is a top priority for patients with rare conditions. Yet, recruiting patients for rare disease clinical trials is challenging, since a small number of patients are spread out geographically, and 50 percent of rare diseases impact the pediatric population.

Ben’s Friends is a network of 40+ web communities for people impacted by rare disease. Through a partnership facilitated by MyRareData, Antidote is offering Ben’s Friends’ 75,000+ members the opportunity to receive information on clinical trials for their condition. When a patient receives a trial match, they will be able to determine whether the trial is right for them through an easy-to-understand online pre-screener. The ultimate goal of this partnership is to accelerate this important research.

“We understand that finding the right clinical trial is a challenge, particularly for the rare disease community,” said Lindsey Wahlstrom-Edwards, Head of Partnerships at Antidote. “That’s why we’re proud to offer digital pre-screening to allow patients to determine what trials are a fit.”

“Research is critical for the rare disease community, and we find that the vast majority of our members opt in to learn about relevant clinical studies,” said Ben Munoz, Founder and Chairman of Ben’s Friends. “With 128,000 unique visits per month, we believe this partnership will allow us to contribute to rare research at scale.”

By connecting rare disease patients with research where they are already looking for help, this collaboration has the potential to make a real difference in the speed at which orphan drugs make it to market.

“Ben’s Friends is the only rare disease online support platform managed by patients themselves,” said JC Muyl, Founder of MyRareData. “They are in a unique position to help rare diseases patients find new and better treatments, and we are pleased to facilitate this partnership.”

If you are a sponsor or CRO recruiting patients for a rare disease trial, please get in touch.

# # #

About Ben’s Friends

Ben’s Friends is a network of over 40 safe and supportive web communities for people whose lives have been touched by a rare disease where patients advocate for and support each other in an atmosphere of medical awareness, understanding and companionship. By helping its members staying well-informed about the disease that they have, and in control of their own medical information, Ben’s Friends’ goal is to put the vast array of experiences of its members to good use in the world of medical research and development, in order to contribute to the quality of life of rare disease patients.

About Antidote

Antidote is a digital health company on a mission to accelerate medical research. In a world where 80 percent of clinical trials are delayed or closed due to lack of participants, Antidote uses precision recruitment to match the right patients with the right trials. Antidote strikes the right balance between technology and human touch to deliver high-quality patient engagement through the integration of data-driven technologies, digital expertise, deep domain experience, a diverse partner network, and personalized patient and site services. Antidote was launched as TrialReach and is based in the US and UK. For more information, please visit or email .

About MyRareData

Founded in 2019, MyRareData builds digital ecosystems that bring together rare patient groups, digital health companies, research and industry. Patients benefit from the latest technology while controlling access to their data; rare patient groups form new sustainable sources of fundraising; digital health partners benefit from higher user buy-in; and industry gains access to valuable patient data for research. Learn more at

MyRareData Media Contact

JC Muyl

Founder, MyRareData

+1 917 579 5692

Ben’s Friends Media Contacts

TJ Lambdin

Co-Executive Director, Ben’s Friends

+1 406 544 3860

Clasina Field

Co-Executive Director, Ben’s Friends

+1 613 639 6713

Ben’s Friends Co-hosts University of Toronto Rare Disease Conference

March 10,2019 – Ben’s Friends, our network of patient communities and Rare Disease Review, a medical and health policy journal hosted a miniconference at Hart House, Toronto. The Conference featured a variety of esteemed speakers, all joined together and shared on their expertise and experience in their individual fields. Ben Munoz, co-founder of Ben’s Friends joined the conference and talked about the challenges of having a rare condition and the importance of peer to peer support when dealing with a rare condition.

Foot and Float to Build 10 New Communities

Ten Ben’s Friends Members and Friends are traveling to Glacier National Park This August for five active days to prove rare Disease Can’t stop – us not on Land or on Water and to raise money to build ten new Ben’s Friends Communities.

Day 1 & 2: Seven Members of our Team are backpacking from West Glacier Montana to the Head of Harrison Lake in the glacier backcountry to camp and fish The rest of the team will be hiking/scootering the Rocky Point Nature Trail on Lake McDonald:

This image has an empty alt attribute; its file name is 602711550de5081a5a5d10fd8081161df7f554a3.png

Day 3: The entire team will be taking on the class 2 & 3 rapids of the Middle Fork of the Flathead river rafting from Moccasin Creek to West Glacier:
This image has an empty alt attribute; its file name is 09b32d9f232a2f1d66aad291467cf2d5431f2511.png

Day 4: The entire Team will be taking the walk of the cedars on this wheelchair and scooter accessible trail. Seven Members of the team will divert at Avalanche Falls to Avalanche Lake.

This image has an empty alt attribute; its file name is 17a2a2d4ba5afff633265ed8133ccd7b136a7d9c.png

Day 5: The entire team will hike/scooter the Swift Current Nature trail At the midpoint of this trail seven members of the team will board a 1930’s wooden boat and cross Lake Josephine where they will hike to and climb on Grinnell Glacier. Before returning to Swift Current Lodge joining the rest of the team to go up the Iceberg Lake trail for Grizzly bear and moose viewing.

This image has an empty alt attribute; its file name is 41ba7517f5a41a414d4075ab2d3813b306f1dac1.png

Our team’s efforts will result in 500 miles of hiking and paddling. This year’s trip is full, but next year is already being planned. But you can still participate. Would you consider pledging a donation for every mile traveled? Even a penny a mile can help support the mission of Ben’s Friends.

Please check out and SHARE our Go Fund Me campaign at:

2018 Ben’s Friends Community Network Update

The following new communities were started in 2018, many of which represent co-conditions that occur with Rare Diseases already supported by Ben’s Friends Patient communities and may be of interest to our existing members:

LivingwithChronicPelvicPain Community – Chronic pelvic pain (CPP) is a disabling disease that causes distress as the quality of life of CPP patients is vastly diminished. In addition, CPP is a public health crisis and is a burden on healthcare expenditure. In the United States, the annual costs for the diagnosis and treatment of CPP are 2.8 billion US . Moreover, to the indirect cost resulting from the absence from work and CPP associated family problems add 550 million US more making the economic burden more than 3.4 billion US $ (Mathias et al., 1996). Yet, the diagnosis of CPP is usually complicated as there are no gold standard guidelines that clearly define this syndrome. Although we have a limited understanding of its etiology, CPP has been found to be correlated with central sensitization, painful bladder syndrome, irritable bowel syndrome, endometriosis and adhesions. As such, in the evaluation of patients, it is imperative to take a comprehensive patient history. Performing physical examinations and ultrasound imaging is of particular value to elucidate the etiology of pain. As CPP patients are at risk for psychological disorders, psychological assessments are critical to diagnose associated psychological disorders and to take these into account in planning a treatment plan for patients. By such evaluation techniques, medical professionals can provide better diagnostic service and patient care to people with CPP. 

LivingWithDysautonomia Community – Dysautonomia is an umbrella term used to describe several different medical conditions that cause a malfunction of the Autonomic Nervous System. The Autonomic Nervous System controls the “automatic” functions of the body that we do not consciously think about, such as heart rate, blood pressure, digestion, dilation and constriction of the pupils of the eye, kidney function, and temperature control. People living with various forms of dysautonomia have trouble regulating these systems, which can result in lightheadedness, fainting, unstable blood pressure, abnormal heart rates, malnutrition, and in severe cases, death. Included conditions are **Postural Orthostatic Tachycardia Syndrome (POTS), Neurocardiogenic Syncope (NCS), and Multiple System Atrophy (MSA)*

LivingWithEpidermolysisBullosa Community – Epidermolysis Bullosa (ep-i-der-mo-lie-sis bu-low-suh), or EB, is a rare genetic connective tissue disorder that affects 1 out of every 20,000 births in the United States (approximately 200 children a year are born with EB). There is no treatment or cure. There are many genetic and symptomatic variations of EB, but all share the prominent symptom of extremely fragile skin that blisters and tears from minor friction or trauma. Internal organs and bodily systems can also be seriously affected by the disease. EB is always painful, often pervasive and debilitating, and is in some cases lethal before the age of 30. EB affects both genders and every racial and ethnic background equally. Daily wound care, pain management, and protective bandaging are the only options available for people with EB.*

LivingWithIdiopathicPulmonaryFibrosis Community – Idiopathic pulmonary fibrosis (IPF) is a type of lung disease that results in scarring (fibrosis) of the lungs for an unknown reason. Over time, the scarring gets worse and it becomes hard to take in a deep breath and the lungs cannot take in enough oxygen. **IPF is a form of interstitial lung disease, primarily involving the interstitium (the tissue and space around the air sacs of the lungs), and not directly affecting the airways or blood vessels. There are many other kinds of interstitial lung disease that can also cause inflammation and/or fibrosis, and these are treated differently. It is important to work with your doctor to determine if you have IPF or another form of interstitial lung disease.

LivingWithNephrotic Syndrome Community – Nephrotic syndrome may occur when the filtering units of the kidney are damaged. This damage allows protein normally kept in the plasma to leak into the urine in large amounts, which reduces the amount of protein in your blood. Since the protein in the blood helps keep fluid in the bloodstream, some of this fluid leaks out of the bloodstream into your tissues, causing swelling, called edema. The swelling may be most noticeable in your legs after you have been standing and around your eyes when you first get up in the morning. Eventually, the swelling in your legs may be there all the time, and it may also occur in other parts of your body. You may notice that your urine foams more than usual because of the amount of protein in it.

LivingWithRaynauds Community – Raynaud’s (ray-NOHZ) disease causes some areas of your body — such as your fingers and toes — to feel numb and cold in response to cold temperatures or stress. In Raynaud’s disease, smaller arteries that supply blood to your skin narrow, limiting blood circulation to affected areas (vasospasm). Women are more likely than men to have Raynaud’s disease, also known as Raynaud or Raynaud’s phenomenon or syndrome. It appears to be more common in people who live in colder climates. Treatment of Raynaud’s disease depends on its severity and whether you have other health conditions.

LivingWithSarcoidosis Community – Sarcoidosis is the growth of tiny collections of inflammatory cells (granulomas) in different parts of your body — most commonly the lungs, lymph nodes, eyes and skin. Doctors believe sarcoidosis results from the body’s immune system responding to an unknown substance, most likely something inhaled from the air. There is no cure for sarcoidosis, but most people do very well with little or only modest treatment. In half of cases, sarcoidosis goes away on its own. In a few cases, however, sarcoidosis may last for years and may cause organ damage.

LivingwithSleepDisorders Community – Sleep disorders number around 88, but most sleep specialists spend much of their time treating the top five: insomnia, sleep apnea, narcolepsy, restless legs syndrome, and periodic limb movements. About one-third of the population has some form of insomnia at any given time, and 10% of that group has chronic insomnia. According to the National Sleep Foundation, a large majority (75%) of Americans say they’ve had at least one symptom of a sleep problem a few nights a week or more within the past year. Ben’s Friends sponsors a separate community for narcolepsy at

One of the new sites we are especially excited about is rebuild of LivingWithRareDisease Community This site now contains links to all our communities as well as an RSS feed of the latest activity in all our community. With the framework of this site, we have housed, a number of instructional videos and slide shows on how to use the Ben’s Friends Communities. These can be accessed from you regular community.

We also have live tech support to help with your computer problems. The support chat is monitored throughout the day by computer geeks who can help with computer issues only. If they are not online, you can leave a message and one of them will get back to you soon.

There are some exciting things happening now and through out 2019 that will continue to make Ben’s Friends the best online support resource for Rare Disease. We’ll keep you posted.

Thanks for a great year and Thank you for your Participation. If you have been away for a while, PLEASE check in and give us an update. Not a day goes by that one of our current members asks about you.

Ben Munoz Joins Antidote Rare Disease Conversation

Antidote, a digital health company who aims to accelerate the development of breakthroughs treatments, making medical research accessible to all, held a roundtable discussion named, “How are Rare Diseases Treated?: An Advocate Conversation”. Ben Munoz, Co-Founder, Ben’s Friends joined the conversation as they delve into the role of medical research in the rare disease space. Read more from Antidote’s post.

Payment Form for BAF + BF Partnership (Hidden)

Hi, Christine Buckley and Team,

We set up this Paypal recurring payments form to make this easier for everyone. Just click the SUBSCRIBE button below and you’ll be redirected to with the next form pre-filled out for you.

You can login with your Paypal account (easiest), or you can click “Pay with your debit or credit card” link to use a debit card.


Payment button for BAF Below

Ben’s Friends Newsletter November 2016




Hi, everyone, I hope this message finds you and your loved ones well.  

Ben’s Friends Patient Communities was founded in 2007; I had just suffered a rare form of brain hemorrhage (AVM) and was looking for online support during surgery and recovery.  I couldn’t find the support I was looking for, so my friend Scott and I started the first Ben’s Friends Patient Community, a support community for AVM survivors.  Since then, Ben’s Friends has created dozens of patient communities and helped connect hundreds of thousands of rare disease patients just like you.  What makes us different is that we are 100% non-profit, created by patients, for patients.  Thank you for being a part of the largest and most caring network of rare disease patient communities on the internet!

–Ben Munoz

Founder, Ben’s Friends /

Ben’s Friends’ Mission

To ensure that patients living with rare diseases or chronic illnesses, as well as their caregivers, have a safe and supportive place to connect with others like them.


Our patient communities used to run on software was originally built almost 10 years ago!  It took over a year of research and hard work but we finally moved our communities over to a newer and more modern software platform. 

The tens of thousands of people who visit our 30+ patient communities every month now have a modern-looking site that is also much more mobile-friendly.  Search is better, discussions are more organized, and the sites are much faster to load.  

You DID it!  Our new online home is 100% thanks to you for volunteering or donating to help rebuild our online home.  Extra special thanks goes out to the Mod Support team for their countless hours of behind-the-scenes work and coordination.

What do you think?  Email me at

Having a rare disease or chronic condition can be quite isolating.  Does this sound familiar? Your friends and family have never heard of your condition.  Your boss or coworkers cannot “see” anything wrong with you, so they dismiss the severity of your condition.  Your healthcare provider gives you a diagnosis, but can’t tell you what to expect.  The stress and fear can be overwhelming and nobody seems to understand what you and your family are going through.   

Patients and their caregivers may feel like they are alone until they find groups such as Ben’s Friends where they can connect with others who have been on their journey.  This is a place to gather information from those who have walked your path, and to share guidance with those who are newly diagnosed and their families.  

Sharing what you know about your condition is vital to other patients and families, but it is also important for those who do research on your condition to hear your voice.  Pharmaceutical companies, device manufacturers, university researchers, and those focused on the economic and social impacts of living with rare and chronic conditions all want to hear about you to understand the way your condition influences your decisions and impacts your day-to-day experiences.

Rare Patient Voice was created to provide patients with and their caregivers with an opportunity to voice their opinions through surveys and interviews to improve medical products and services.  Founded in 2013, Rare Patient Voice has over 100 different panels representing over 30,000 patients and caregivers in the US and Canada.  The company’s vision is to be the catalyst for patients in all disease categories to share their experiences confidentially with those who can make a difference for those living with rare and chronic conditions.

Rare Patient Voice meets patients and caregivers at events such as conferences, walks, and educational forums, and invites them to join research panels.  Participants receive a gift card for joining the panel, and when they participate in a study, they receive $100 for an hour of their time.  Over the past three years, Rare Patient Voice has paid patients and caregivers over $1 million dollars for sharing their opinions.  Participants benefit from the process on several levels, as one participant noted, “The money is nice, but getting our voices heard is amazing.”

If you would like to share your experience, please join Rare Patient Voice at

This is a sponsored post. CLICK HERE to learn more about sponsored posts.

Just the Numbers

Communities: 34

Friends: 30,000+


Last month, launched a Indiegogo fundraiser to help upgrade their community.  The community raised over $2,000, smashing the goal of $500.  Amazing stuff.

If you would like to launch a fundraiser for your community, we can take care of the details.  Just email Todd Hall at

How You Can Help

If your community has made your life a little better and you would like to give back, here are some ways you can help.  Email to get started.

Become a Community Greeter

  • Say hello to new members and be available to answer any questions they may have. (0-1 hour per week)

Become a Community Moderator

  • Organize discussions and help make sure the community warm and friendly for everyone. (2-3 hours per week)

Write a Newsletter

  • Write content for our quarterly newsletter or for one of our monthly newsletters. (1-2 hours per week)

Manage Social Media

  • Post inspirational content to thousands of followers on our Twitter and FB pages. (1-2 hours per week)

Email if you have some spare time and would like to give back to patients.

Contact Us


Why Ben’s Friends Moved Its Patient Support Communities to Discourse from Ning

Ben’s Friends History

When we started Ben’s Friends Patient Support Communities in 2007, our mission was to provide support for the millions of patients with rare diseases across the world. Ben Munoz, our co-founder, had suffered from a rare AVM, kind of like a brain aneurysm, and he couldn’t find a single person in the world to talk to about his condition. Before Ben’s Friends, the lack of information and personal connection meant that patients with rare diseases had to suffer through their disease alone.

We knew that by leveraging the power of the Internet, we could bring together patients across the world. We were recent Kellogg MBA’s with very little money and we had an inclination that the communities would have a hard time monetizing. That meant that venture capital funding would be difficult to find and we were better off going the 501C3 non profit route.

In 2007, Ning Was a Godsend

We were resourceful and found Ning. At the time, Ning was piloted by a team that included Marc Andreessen, the Co-Founder of Netscape, and was backed by some of the finest venture capitalists in the world. Ning had the resources that we didn’t to build beautiful and functional social networking software. To Ben’s Friends, Ning was a godsend and we enthusiastically built over 35 distinct rare disease patient support communities on it.

Ben’s Friends flourished and we became one of the largest communities for rare diseases in the world. We recruited a volunteer moderator group of hundreds of fellow patients and loved ones that eventually provided support to millions of patients in need. The volunteer moderators are the real heroes of Ben’s Friends. They worked tirelessly and for free to make sure others didn’t suffer alone.  

Ben’s Friends Needed A New Home

As the venture capital dried up, Ning was acquired by different corporate entities. Ning became severely underfunded and the quality of the service suffered. Ben’s Friends needed a new home.

Discourse Welcomed Ben’s Friends with Open Arms

After scouring the Internet and evaluating tons of software services, we chose Discourse. I’m happy to announce that with the heroic efforts of Jeff Atwood, Erlend Soghe Heggen, Neil Lalonde, Arpit Jalan and the rest of the Discourse Team,  along with Tom, Rose and the rest of the Ben’s Friends Team efforts, Ben’s Friends is fully migrated off of Ning and the communities are humming on Discourse. Thank you Discourse!!!

Why did Ben’s Friends Choose Discourse?

Discourse is open source software. It’s a new company called “Civilised Discourse Construction Kit Inc.” (CDCK for short) formed by some of the same people who used to work on Stack Exchange, which is a very successful creator of online Q&A communities. Discourse is not the same software as Stack Exchange, but many of the lessons learned through that experience have been incorporated into Discourse. Discourse is constantly being improved by a cadre of open source developers. Ben’s Friends will be a huge beneficiary of their collective efforts.

The architecture of Discourse communities is brilliant, which leads to a very simple user experience for Ben’s Friends members. The software is hosted for a small fee (cheaper than Ning), which means Ben’s Friends doesn’t have to hire expensive IT staff or mess around with servers. Ben’s Friends on Discourse just works.

Discourse’s Export/Import Tool Greatly Simplified Migration

Jeff, Erlend, Neil Arpit and Team went the extra mile for Ben’s Friends by building an information Export/Import from Ning. That meant that the millions of posts, pictures and discussions on the Ben’s Friends communities were not lost. Members can find their old Ning content on Discourse! The Export/Import tool and support ended up saving Ben’s Friends hundreds of thousands of dollars.

Early Feedback on the Migration

The migration has been complete for only a week and we’re already seeing greater levels of interaction. Members are still getting used to the new format but they are sending us lots of encouraging notes. One immediate improvement has been the mobile interface. Over 50% of Ben’s Friends traffic comes from mobile devices and the new Discourse interface is easy to use.

Thank You Discourse

The transition from Ning to Discourse will be an inflection point for Ben’s Friends. Our donors underwrote the project with more than $40,000 of contributions. Many of those contributions came from community members and patients. It’s rewarding to be able to tell them that the migration was successful and Ben’s Friends can get back to the business of supporting patients and building new communities.

Thank you Discourse for letting Ben’s Friends focus on what we love – bringing support to patients with rare diseases across the world.

If you’re inspired by Ben’s Friends mission and the hundreds of volunteer moderators that make the support communities successful, you can support our growth by donating.

BioBlast Matches Up To $5,000 In Donations To Help Build A New Home For Ben’s Friends

BioBlast Pharma will match each dollar up to $5,000 donated to Ben’s Friends for the migration of the Oculopharyngeal Muscular Dystrophy (OPMD) and Spinocerebellar Ataxia Type 3 (SCA3) patient communities to a new online platform. BioBlast is a clinical-stage global pharmaceutical company focused on the research and development of treatments for people living with rare diseases.

“We are focused on improving the lives of people suffering with symptoms of rare genetic diseases, like OPMD and SCA3,” stated Paul Firuta, Chief Commercial Officer, BioBlast, “and are excited about the opportunity to support Ben’s Friends in creating a new online homes for the OPMD and SCA3 communities.”

Ben’s Friends is hoping to complete the migration of the OPMD and SCA3 communities early 2016.

CMX Hub Features Ben’s Friends

Ben’s Friends co-founder Ben Munoz shared in CMX Hub how to build trust from patients with rare diseases.

According to Munoz, making members feel welcomed is key. The welcome is the most important piece of the community membership cycle. When a new member joins, they are warmly greeted by lots of veteran members who trusted the community and so new members feel the warmth and friendliness. Read more from this article.